Veterinary Immunodiagnostics Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 2.94 Billion
CAGR (2026-2031)	7.98%
Fastest Growing Segment	Analyzers
Largest Market	North America
Market Size (2031)	USD 4.66 Billion

Market Overview

The Global Veterinary Immunodiagnostics Market will grow from USD 2.94 Billion in 2025 to USD 4.66 Billion by 2031 at a 7.98% CAGR. Veterinary immunodiagnostics constitutes a specialized segment of animal healthcare that utilizes antigen-antibody interactions to detect infectious pathogens, hormonal levels, and immune responses in companion and livestock animals. The market is fundamentally propelled by the rising global population of pets and the intensifying demand for efficient food animal production, which necessitates rigorous disease surveillance. These drivers are reinforced by the increasing prevalence of zoonotic diseases, creating a structural requirement for precise screening tools that remains distinct from temporary technological trends. The economic viability of this sector is substantial; according to the American Pet Products Association, in 2024, veterinary care and product sales reached $39.8 billion in the United States.

However, a significant impediment to broader market expansion is the prohibitive cost associated with advanced immunodiagnostic assays, which restricts their accessibility in price-sensitive regions. While developed markets continue to integrate these diagnostic modalities, the financial burden remains a barrier for smaller veterinary practices and developing economies. This challenge is frequently compounded by a scarcity of veterinary professionals trained to interpret complex diagnostic results, thereby limiting the universal penetration of high-precision immunodiagnostic technologies.

Key Market Drivers

The growing trend of pet ownership and animal humanization acts as a primary catalyst for the Global Veterinary Immunodiagnostics Market, fundamentally altering the economic landscape of veterinary care. As owners increasingly view companion animals as integral family members, there is a heightened willingness to invest in preventative healthcare and advanced diagnostic screening. This shift is financially empowered by the rapid expansion of the pet insurance sector, which mitigates the cost barrier for frequent and complex testing. According to the North American Pet Health Insurance Association, April 2024, in the '2024 State of the Industry Report', the total premium volume for pet health insurance in the United States reached $3.9 billion in 2023, reflecting a double-digit year-over-year increase. This surge in insured pets directly correlates with higher utilization rates of immunodiagnostic panels, as veterinarians can prescribe comprehensive diagnostic workups with greater assurance of client compliance and reimbursement.

Simultaneously, the rising prevalence of zoonotic and infectious animal diseases drives the critical need for rapid, sensitive detection tools in both livestock and companion animal sectors. The emergence of transboundary pathogens threatens global food security and public health, necessitating robust surveillance protocols that rely heavily on immunodiagnostic technologies. A pertinent example of this volatility occurred recently in the livestock sector; according to the USDA Animal and Plant Health Inspection Service, April 2024, in the 'USDA Confirms Highly Pathogenic Avian Influenza in Dairy Herd' press release, the agency confirmed the unprecedented detection of the virus in dairy cattle across multiple states, triggering immediate demand for targeted diagnostic testing. The commercial scale of these combined market forces is evidenced by the financial performance of industry leaders. According to IDEXX Laboratories, February 2024, in the 'Fourth Quarter and Full Year 2023 Results' announcement, the company reported annual revenues of $3.66 billion for 2023, underscoring the substantial economic value generated by the ongoing demand for veterinary diagnostic solutions.

Download Free Sample Report

Key Market Challenges

The prohibitive cost associated with advanced immunodiagnostic assays stands as a primary obstruction to the expansive growth of the Global Veterinary Immunodiagnostics Market. While these diagnostic tools offer high precision for detecting pathogens and immune responses, their elevated pricing structure severely restricts their adoption, particularly within price-sensitive geographies and smaller independent veterinary practices. This financial barrier forces veterinarians and livestock producers to prioritize essential treatments over rigorous screening, leading to a lower volume of test utilization. Consequently, the market faces a bottleneck where the technological capability to detect diseases exists, but the economic capacity to deploy these tools at scale is absent, thereby stalling potential revenue streams in developing economies.

This economic strain directly correlates with reduced veterinary engagement, which hampers the overall demand for diagnostic consumption. When pet owners and producers face rising healthcare expenses, routine and diagnostic visits are often the first to be curtailed. According to the American Veterinary Medical Association, in 2024, patient visits to veterinary practices decreased by 2.3% compared to the previous year. This decline in clinical foot traffic inevitably results in fewer diagnostic panels being run, directly reducing the serviceable addressable market for immunodiagnostic products. As long as these assays remain financially out of reach for a significant portion of the global veterinary sector, the market’s growth trajectory will remain constrained by these affordability thresholds.

Key Market Trends

The emergence of biosensor-based immunodiagnostic technologies is revolutionizing veterinary practice by delivering reference-laboratory precision directly at the point of care. Unlike standard lateral flow assays, these advanced platforms utilize technologies such as Bulk Acoustic Wave (BAW) sensors to detect hormones and pathogens with superior sensitivity, enabling immediate, data-driven treatment decisions during patient visits. This technological shift is gaining significant commercial traction as clinics increasingly prioritize diagnostic speed without compromising analytical accuracy. According to Investing.com, November 2024, in the 'Zomedica reports record Q3 revenue' article, Zomedica announced an 80% increase in TRUFORMA platform sales for the third quarter of 2024, validating the accelerating adoption of these high-precision diagnostic instruments in veterinary settings.

Simultaneously, the commercialization of novel biomarkers for early disease detection is expanding the market’s scope beyond infectious disease management into oncology and chronic care. Diagnostics are increasingly utilizing circulating nucleosomes and other non-invasive markers to facilitate affordable, routine screening of cancers before clinical symptoms manifest. This transition towards preventative medicine generates new recurring revenue streams for practices while significantly improving patient prognoses through earlier intervention. Highlighting this rapid market uptake, according to VolitionRx Limited, November 2024, in the 'Third Quarter 2024 Financial Results and Business Update', the company reported selling over 110,000 Nu.Q Vet Cancer Tests in the first nine months of 2024, with Q3 revenue rising 307% year-over-year.

Segmental Insights

Based on authoritative market research, the Analyzers segment is recognized as the fastest-growing category within the Global Veterinary Immunodiagnostics Market. This rapid expansion is primarily driven by the increasing adoption of automated diagnostic systems that significantly streamline clinical workflows and minimize manual errors. Veterinary professionals are prioritizing these advanced devices due to their ability to deliver high-throughput performance and precise results, which are essential for the timely detection of infectious diseases. Furthermore, the rising demand for point-of-care testing is accelerating the deployment of compact and user-friendly analyzers, thereby reinforcing the segment's strong upward trajectory.

Regional Insights

North America holds a dominant position in the global veterinary immunodiagnostics market, primarily driven by widespread pet ownership and substantial expenditure on animal healthcare. The region benefits from a well-established infrastructure of veterinary hospitals and clinics that prioritize preventative screening and disease management. Additionally, the presence of key industry players within the United States facilitates widespread product accessibility and distribution. The market is further supported by regulatory oversight from the United States Department of Agriculture, which establishes standards for veterinary biologics and diagnostic kits, thereby fostering a stable environment for industry development.

Recent Developments

In July 2024, BioNote USA announced a strategic partnership with MWI Animal Health to distribute its Vcheck line of quantitative in-clinic analyzers and biomarker tests. This collaboration significantly expanded the availability of BioNote's advanced immunofluorescence technology, which utilizes europium nanoparticles for high-sensitivity detection, to veterinary practices across the United States. The agreement included the distribution of tests for critical cardiac and inflammatory markers, such as NT-proBNP and Troponin I. By leveraging MWI’s extensive logistics network, the partnership aimed to provide veterinarians with greater access to affordable, real-time diagnostic tools that support rapid, data-driven medical decisions.
In June 2024, IDEXX Laboratories, Inc. launched the Catalyst Pancreatic Lipase Test, a single-slide diagnostic solution compatible with its extensive base of in-clinic Catalyst analyzers. This innovative immunoassay enables veterinary teams to rapidly assess pancreatic health in both canine and feline patients by measuring pancreas-specific lipase levels in the blood. The test was developed to provide reference-laboratory quality results at the point of care, allowing for immediate diagnosis and treatment planning during patient visits. This product launch represented a significant enhancement to the company's diagnostic menu, aimed at streamlining clinic workflow and improving the management of pancreatitis.
In January 2024, Antech Diagnostics announced the commercial launch of the Nu.Q Canine Cancer Test at the VMX veterinary conference in Orlando. This breakthrough liquid biopsy assay was designed to operate on the company's Element i+ Immunodiagnostic Analyzer, providing veterinary professionals with a rapid and cost-effective solution for cancer screening. The test measures circulating nucleosomes to support the early detection of prevalent canine malignancies, such as lymphoma and hemangiosarcoma, using only a small plasma sample. By offering accurate results in approximately six minutes, the technology enables clinicians to make timely decisions and improve patient outcomes during routine wellness exams.
In January 2024, VMRD, Inc. announced the expansion of its patient-side diagnostic portfolio with the introduction of the VMRD SAA for Canine test. This new immunodiagnostic offering complements the company’s existing Serum Amyloid A tests for feline and equine patients, allowing veterinarians to detect acute inflammation and infection across a broader range of species. The lateral flow test was designed to provide rapid, quantitative results within ten minutes on a handheld reader, facilitating immediate clinical assessment. This development addressed the critical need for reliable biomarkers that can objectively monitor patient health and response to treatment more effectively than traditional clinical signs.

Key Market Players

Zoetis Inc.
IDEXX Laboratories, Inc.
Abaxis, Inc.
Biogal-Galed Labs Ltd.
Boehringer Ingelheim Animal Health GmbH
Thermo Fisher Scientific Inc.
Heska Corporation
Virbac S.A.
Merial Limited
Agrolabo S.p.A.

By Product Type	By Animal Type	By Technology	By Application	By End User	By Distribution Channel	By Region
Analyzers Consumables	Livestock (Cattle, Pigs, Poultry, Others) Companion (Feline, Equine, Canine, Others)	ELISA Chemiluminescence Immunoassay Fluorescent Immunoassay Colorimetric Immunoassay	Infectious Disease Autoimmune Disorder Endocrinology Oncology Bone and Mineral Diseases Others	Reference Laboratories Academic and Research Institutes Veterinary Hospitals & Clinics Point of care/In-house testing	Hospitals Retail Stores Pharmacies & Drug Stores and E-Commerce	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Veterinary Immunodiagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Immunodiagnostics Market, By Product Type:

Analyzers
Consumables

Veterinary Immunodiagnostics Market, By Animal Type:

Livestock (Cattle, Pigs, Poultry, Others)
Companion (Feline, Equine, Canine, Others)

Veterinary Immunodiagnostics Market, By Technology:

ELISA
Chemiluminescence Immunoassay
Fluorescent Immunoassay
Colorimetric Immunoassay

Veterinary Immunodiagnostics Market, By Application:

Infectious Disease
Autoimmune Disorder
Endocrinology
Oncology
Bone and Mineral Diseases
Others

Veterinary Immunodiagnostics Market, By End User:

Reference Laboratories
Academic and Research Institutes
Veterinary Hospitals & Clinics
Point of care/In-house testing

Veterinary Immunodiagnostics Market, By Distribution Channel:

Hospitals
Retail Stores
Pharmacies & Drug Stores and E-Commerce

Veterinary Immunodiagnostics Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Immunodiagnostics Market.

Available Customizations:

Global Veterinary Immunodiagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Veterinary Immunodiagnostics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Immunodiagnostics Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type (Analyzers, Consumables)

5.2.2. By Animal Type (Livestock (Cattle, Pigs, Poultry, Others), Companion (Feline, Equine, Canine, Others))

5.2.3. By Technology (ELISA, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassay)

5.2.4. By Application (Infectious Disease, Autoimmune Disorder, Endocrinology, Oncology, Bone and Mineral Diseases, Others)

5.2.5. By End User (Reference Laboratories, Academic and Research Institutes, Veterinary Hospitals & Clinics, Point of care/In-house testing)

5.2.6. By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores and E-Commerce)

5.2.7. By Region

5.2.8. By Company (2025)

5.3. Market Map

6. North America Veterinary Immunodiagnostics Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By Animal Type

6.2.3. By Technology

6.2.4. By Application

6.2.5. By End User

6.2.6. By Distribution Channel

6.2.7. By Country

6.3. North America: Country Analysis

6.3.1. United States Veterinary Immunodiagnostics Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By Animal Type

6.3.1.2.3. By Technology

6.3.1.2.4. By Application

6.3.1.2.5. By End User

6.3.1.2.6. By Distribution Channel

6.3.2. Canada Veterinary Immunodiagnostics Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By Animal Type

6.3.2.2.3. By Technology

6.3.2.2.4. By Application

6.3.2.2.5. By End User

6.3.2.2.6. By Distribution Channel

6.3.3. Mexico Veterinary Immunodiagnostics Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By Animal Type

6.3.3.2.3. By Technology

6.3.3.2.4. By Application

6.3.3.2.5. By End User

6.3.3.2.6. By Distribution Channel

7. Europe Veterinary Immunodiagnostics Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Animal Type

7.2.3. By Technology

7.2.4. By Application

7.2.5. By End User

7.2.6. By Distribution Channel

7.2.7. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Veterinary Immunodiagnostics Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By Animal Type

7.3.1.2.3. By Technology

7.3.1.2.4. By Application

7.3.1.2.5. By End User

7.3.1.2.6. By Distribution Channel

7.3.2. France Veterinary Immunodiagnostics Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By Animal Type

7.3.2.2.3. By Technology

7.3.2.2.4. By Application

7.3.2.2.5. By End User

7.3.2.2.6. By Distribution Channel

7.3.3. United Kingdom Veterinary Immunodiagnostics Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product Type

7.3.3.2.2. By Animal Type

7.3.3.2.3. By Technology

7.3.3.2.4. By Application

7.3.3.2.5. By End User

7.3.3.2.6. By Distribution Channel

7.3.4. Italy Veterinary Immunodiagnostics Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By Animal Type

7.3.4.2.3. By Technology

7.3.4.2.4. By Application

7.3.4.2.5. By End User

7.3.4.2.6. By Distribution Channel

7.3.5. Spain Veterinary Immunodiagnostics Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By Animal Type

7.3.5.2.3. By Technology

7.3.5.2.4. By Application

7.3.5.2.5. By End User

7.3.5.2.6. By Distribution Channel

8. Asia Pacific Veterinary Immunodiagnostics Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Animal Type

8.2.3. By Technology

8.2.4. By Application

8.2.5. By End User

8.2.6. By Distribution Channel

8.2.7. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Veterinary Immunodiagnostics Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By Animal Type

8.3.1.2.3. By Technology

8.3.1.2.4. By Application

8.3.1.2.5. By End User

8.3.1.2.6. By Distribution Channel

8.3.2. India Veterinary Immunodiagnostics Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By Animal Type

8.3.2.2.3. By Technology

8.3.2.2.4. By Application

8.3.2.2.5. By End User

8.3.2.2.6. By Distribution Channel

8.3.3. Japan Veterinary Immunodiagnostics Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By Animal Type

8.3.3.2.3. By Technology

8.3.3.2.4. By Application

8.3.3.2.5. By End User

8.3.3.2.6. By Distribution Channel

8.3.4. South Korea Veterinary Immunodiagnostics Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product Type

8.3.4.2.2. By Animal Type

8.3.4.2.3. By Technology

8.3.4.2.4. By Application

8.3.4.2.5. By End User

8.3.4.2.6. By Distribution Channel

8.3.5. Australia Veterinary Immunodiagnostics Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product Type

8.3.5.2.2. By Animal Type

8.3.5.2.3. By Technology

8.3.5.2.4. By Application

8.3.5.2.5. By End User

8.3.5.2.6. By Distribution Channel

9. Middle East & Africa Veterinary Immunodiagnostics Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By Animal Type

9.2.3. By Technology

9.2.4. By Application

9.2.5. By End User

9.2.6. By Distribution Channel

9.2.7. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Veterinary Immunodiagnostics Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By Animal Type

9.3.1.2.3. By Technology

9.3.1.2.4. By Application

9.3.1.2.5. By End User

9.3.1.2.6. By Distribution Channel

9.3.2. UAE Veterinary Immunodiagnostics Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By Animal Type

9.3.2.2.3. By Technology

9.3.2.2.4. By Application

9.3.2.2.5. By End User

9.3.2.2.6. By Distribution Channel

9.3.3. South Africa Veterinary Immunodiagnostics Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By Animal Type

9.3.3.2.3. By Technology

9.3.3.2.4. By Application

9.3.3.2.5. By End User

9.3.3.2.6. By Distribution Channel

10. South America Veterinary Immunodiagnostics Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product Type

10.2.2. By Animal Type

10.2.3. By Technology

10.2.4. By Application

10.2.5. By End User

10.2.6. By Distribution Channel

10.2.7. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Veterinary Immunodiagnostics Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product Type

10.3.1.2.2. By Animal Type

10.3.1.2.3. By Technology

10.3.1.2.4. By Application

10.3.1.2.5. By End User

10.3.1.2.6. By Distribution Channel

10.3.2. Colombia Veterinary Immunodiagnostics Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product Type

10.3.2.2.2. By Animal Type

10.3.2.2.3. By Technology

10.3.2.2.4. By Application

10.3.2.2.5. By End User

10.3.2.2.6. By Distribution Channel

10.3.3. Argentina Veterinary Immunodiagnostics Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product Type

10.3.3.2.2. By Animal Type

10.3.3.2.3. By Technology

10.3.3.2.4. By Application

10.3.3.2.5. By End User

10.3.3.2.6. By Distribution Channel

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Veterinary Immunodiagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Zoetis Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. IDEXX Laboratories, Inc.

15.3. Abaxis, Inc.

15.4. Biogal-Galed Labs Ltd.

15.5. Boehringer Ingelheim Animal Health GmbH

15.6. Thermo Fisher Scientific Inc.

15.7. Heska Corporation

15.8. Virbac S.A.

15.9. Merial Limited

15.10. Agrolabo S.p.A.

16. Strategic Recommendations

17. About Us & Disclaimer

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Veterinary Immunodiagnostics Market in 2025?

Which is the dominating region in the Global Veterinary Immunodiagnostics Market?

Which is the fastest growing segment in the Global Veterinary Immunodiagnostics Market?

What is the expected growth rate of the Global Veterinary Immunodiagnostics Market?